Spineway SA ALSPW
EURONEXT · France · Health Technology
€0.1110+0.00 (+2.78%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements – UnauditedH1 2026H1 2025Revenue5,7255,573Cost of sales(1,882)(1,702)Gross margin% of revenue3,84367%3,87069%Net operating expenses Of which general operating costs(5,489) (2,107)(5,068) (2,086)Of which personnel expensesOf which other op. income and expensesOf which dep., amort., and provisions(2,467)(512)(403)(2,
Ecully, April 30, 2026 – 6:00 p.m. First-quarter 2026 revenue High order volumeSlower-than-expected normalization of supply chains2026: growth trajectory confirmed In thousands of euros20262025Change as a %Q1 revenue2,1762,828-23% Unaudited consolidated data Spineway, a specialist in innovative implants for the treatment of severe spine disorders, recorded revenue of €2.2 million in the first quarter of 2026. Following strong growth in the fourth quarter of 2025 (+38%), the slowdown observed in
Ecully, April 7, 2026 – 8:00 a.m. SPINEWAY Minutes of the General Meeting of April 2, 2026 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Thursday 2 April 2026 at 10.00 am at the company’s registered office, 7 allée Moulin Berger in Ecully (69). The defaulting shareholders were represented by SELARL TULIER POLGE ALIREZAI, as ad hoc representative appointed by Order of the President of the Lyon Commercial Court dated February 24, 202
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.